Welcome to LookChem.com Sign In|Join Free
  • or
L-Leucine, N-[(1,1-dimethylethoxy)carbonyl]-, [4-(carboxymethyl)phenyl]methyl ester is a modified form of the essential amino acid leucine, commonly utilized in biochemistry and pharmaceuticals. L-Leucine, N-[(1,1-dimethylethoxy)carbonyl]-,
[4-(carboxymethyl)phenyl]methyl ester is designed to enhance stability and bioavailability, making it a key component in drug delivery systems and a versatile building block for the synthesis of innovative pharmaceutical compounds. Its unique chemical structure facilitates controlled release and targeted drug delivery, which is crucial for the development of advanced drug formulations. Moreover, it has been investigated for its potential bioactive properties, indicating possible applications in treating a range of medical conditions.

73401-70-4

Post Buying Request

73401-70-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

73401-70-4 Usage

Uses

Used in Pharmaceutical Industry:
L-Leucine, N-[(1,1-dimethylethoxy)carbonyl]-, [4-(carboxymethyl)phenyl]methyl ester is used as a component in drug delivery systems for its ability to improve the stability and bioavailability of pharmaceutical compounds. Its controlled release and targeted delivery capabilities are essential for enhancing the efficacy and safety of various medications.
Used in Biochemical Research:
In the field of biochemistry, L-Leucine, N-[(1,1-dimethylethoxy)carbonyl]-, [4-(carboxymethyl)phenyl]methyl ester serves as a valuable building block for the synthesis of novel pharmaceutical compounds. Its unique chemical structure allows researchers to explore new avenues in drug development, potentially leading to the discovery of more effective treatments for various diseases and conditions.
Used in Medical Treatments:
L-Leucine, N-[(1,1-dimethylethoxy)carbonyl]-, [4-(carboxymethyl)phenyl]methyl ester is studied for its potential bioactive properties, which may contribute to the treatment of various medical conditions. Its role in drug delivery and synthesis could lead to the development of new therapeutic agents that address unmet medical needs and improve patient outcomes.

Check Digit Verification of cas no

The CAS Registry Mumber 73401-70-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,4,0 and 1 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 73401-70:
(7*7)+(6*3)+(5*4)+(4*0)+(3*1)+(2*7)+(1*0)=104
104 % 10 = 4
So 73401-70-4 is a valid CAS Registry Number.

73401-70-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Boc-Leu-OMPA

1.2 Other means of identification

Product number -
Other names 2-tert-Butoxycarbonylamino-4-methyl-pentanoic acid 4-carboxymethyl-benzyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:73401-70-4 SDS

73401-70-4Downstream Products

73401-70-4Relevant academic research and scientific papers

Improved synthesis of preformed Boc-aminoacid-bridging groups for use in solid phase peptide synthesis

Calmes,Cavelier,Daunis,Elyacoubi,Jacquier

, p. 2003 - 2006 (2007/10/02)

Preformed Boc-aminoacid-bridging groups are synthesized by an improved method, using Tmse temporary protection of the starting 4-(halomethyl)phenylacetic acid or bromoacetic acid.

Design and Synthesis of Multidetachable Resin Supports for Solid-Phase Peptide Synthesis

Tam, James P.,Tjoeng, Foe S.,Merrifield, R. B.

, p. 6117 - 6127 (2007/10/02)

A new and unusually versatile class of supports for solid-phase peptide synthesis has been developed.It contains two orthogonally removable ester bonds, allowing the selective cleavage of the individual bonds by a variety of reagents.The synthetic peptide can be obtained in a free or protected form, or with a removable spacer group still attached at the carboxyl terminus.Two such multidetachable resin supports have been developed in which selective cleavage is by acidolysis, photolysis, or nucleophilic cleavage; they are (1) tert-butoxycarbonylaminoacyl-2-propionyl-copoly(styrene-divinylbenzene) resin (Pop-resin) and tert-butoxycarbonylaminoacyl-4--3-nitrobenzamidomethyl-copoly(styrene-divinylbenzene) resin (Pon-resin).The value of these resins was demonstrated by the stepwise synthesis of Leu-enkephalin and angiotensin II.In addition, applications of this class of supports for fragment synthesis were described.The minimization of side reactions associated with peptide anchored to photolabile resins in the ordinary way was demonstrated.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 73401-70-4